Limit search to available items
Book Cover

Title Fragment-based drug discovery / [editors] Steven Howard, Chris Abell
Published [Cambridge] : Royal Society of Chemistry, 2015
Online access available from:
Royal Society of Chemistry eBooks    View Resource Record  


Description 1 online resource
Series RSC drug discovery ; 47
RSC drug discovery series ; 47
Summary Fragment-based drug discovery is a rapidly evolving area of research, which has recently seen new applications in areas such as epigenetics, GPCRs and the identification of novel allosteric binding pockets. The first fragment-derived drug was recently approved for the treatment of melanoma. It is hoped that this approval is just the beginning of the many drugs yet to be discovered using this fascinating technique. This book is written from a Chemist's perspective and comprehensively assesses the impact of fragment-based drug discovery on a wide variety of areas of medicinal chemistry. It will prove to be an invaluable resource for medicinal chemists working in academia and industry, as well as anyone interested in novel drug discovery techniques
Notes Includes index
Online resource; title from title details screen (Royal Society of Chemistry, viewed August 17, 2015)
Subject Drug development.
Drugs -- Design.
Ligands (Biochemistry)
Form Electronic book
Author Abell, C., editor
Howard, Steven, PhD, editor
Royal Society of Chemistry (Great Britain)
ISBN 1782620931 (electronic bk)
1849739080 (Trade Cloth)
9781782620938 (electronic bk)